Objectives: The prevalence of viral hepatitis varies worldwide. Although the prevalence of hepatitis A virus (HAV) and hepatitis B virus (HBV) infection is generally low in Western countries, pockets of higher prevalence may exist in areas with large immigrant populations. The aim of this study was to obtain further information on the prevalence of viral hepatitis in a multi-ethnic area in the Netherlands. Methods: We conducted a community-based study in a multi-ethnic neighborhood in the city of Rotterdam, the Netherlands, including both native Dutch and migrant participants, who were tested for serological markers of hepatitis A, hepatitis B, and hepatitis C infection. Results: Markers for hepatitis A infection were present in 68% of participants. The prevalence of hepatitis B core antibodies (anti-HBc), a marker for previous or current infection, was 20% (58/ 284). Prevalence of hepatitis A and B varied by age group and ethnicity. Two respondents (0.7%) had chronic HBV infection. The prevalence of hepatitis C was 1.1% (3/271). High levels of isolated anti-HBc were found. Conclusions: We found a high prevalence of (previous) viral hepatitis infections. This confirms previous observations in ethnic subgroups from a national general population study and illustrates the high burden of viral hepatitis in areas with large immigrant populations. #
Introduction
The prevalences of hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV) infections vary worldwide. While the geographical distributions of HAV and HBV differ greatly between Western and non-Western countries, this does not hold for HCV. Hepatitis A is transmitted fecal-orally, hepatitis B through sexual contact, blood-blood contact, and perinatally from mother to child, and hepatitis C mainly parenterally. In the epidemiology of especially HAV and HBV in low endemic regions, the import of cases from intermediate or high endemic regions plays an important role.
A population-based seroprevalence study in the Netherlands in 1995/1996, the so-called Pienter study, showed that 34% of the population had antibodies to HAV. The prevalence increased with age and was higher in people of non-Dutch ethnicity. 1 In the Pienter study, a two-stage cluster sampling technique was used to draw a nationwide sample. In each of five geographic regions, with approximately equal numbers of inhabitants, eight municipalities were sampled proportionally to their size. Within each municipality, an agestratified sample of 380 individuals was drawn from the population register.
Although the HBV prevalence is generally low in Western countries, pockets of higher HBV prevalence exist in areas with large immigrant populations. Therefore national prevalence figures can underestimate the burden of HBV infection. In the Netherlands, in the Pienter general population study, the prevalence of antibodies to hepatitis B core antigen (anti-HBc), a marker for past or current infection, was 2.1%, and the prevalence of hepatitis B surface antigen (HBsAg), which indicates chronic infection, was 0.2%. 2 The prevalence of chronic HBV in the Pienter study sample is believed to be an underestimate due to under-representation of the non-Dutch population. An adjusted estimate, based on the chronic HBV prevalence in the countries of origin of first generation immigrants, defined as foreign born, and their proportion in the Dutch population, resulted in a new general population HBsAg prevalence estimate of 0.36%. 3 The prevalence of hepatitis C in the general Dutch population was estimated at 0.1% in the Pienter study. Most of the HCV-infected individuals had no known risk factors. 4 In this paper we present the results of a community-based study in a multi-ethnic neighborhood in the city of Rotterdam, the Netherlands. Rotterdam has a large immigrant population, with 26% of the population being first generation immigrants and 19% second generation immigrants, in contrast to 10% and 9%, respectively, in the Netherlands overall (Statistics Netherlands, data 2006). The aim of this study was to obtain further information on the prevalence of viral hepatitis in an area with a large immigrant population.
Patients and methods

Study population
A community-based study in a multi-ethnic neighborhood of nearly 13 000 inhabitants in the south of Rotterdam was carried out in 2004. We aimed at including a maximum number of 800 participants in the study, a number based on power calculations taking into consideration both feasibil-ity and acceptable precision of prevalence rates in subgroups. People aged 18 to 65 years from the six main ethnic groups in the neighborhood, namely Dutch, Moroccan, Turkish, Surinamese, Antillean, and Cape Verdean, were included in the sample. Ethnicity was based on the country of birth of the person or of one of the parents. A random sample of 1787 inhabitants of the neighborhood was drawn from the municipal administration, stratified by ethnic group. The number needed in each ethnic group was calculated based on an expected overall response of 50%, with oversampling of those ethnic groups where a lower response rate was anticipated. Foreign-born persons are referred to as first generation migrants (FGM), persons born in the Netherlands but with one of the parents born abroad, as second generation migrants (SGM). Individuals were invited by mail for a personal consultation at the community center. Reminder letters were sent to groups where response lagged. During the visit a blood sample was taken, and based on an interview in the native language, a questionnaire was filled in by the interviewer. The questionnaire included items on travel history, sexual behavior, and risk factors such as intravenous drug use and other parenteral exposures (e.g., medical procedures, tattoo) in the Netherlands and abroad. Respondents provided written informed consent and the study was approved by the Medical Ethical Review Board of the Erasmus Medical Center. The respondents received their test results by mail and were offered free vaccination at the Municipal Public Health Service (MPHS) if they were susceptible to HAV/ HBV.
Laboratory testing
All blood samples were tested for anti-HAV, anti-HCV, anti-HBc, and HBsAg. Samples positive for anti-HBc and negative for HBsAg were further tested for antibodies to hepatitis B surface antigen (anti-HBs), and in the case of negative anti-HBs also for antibodies to hepatitis B e-antigen (anti-HBe). An anti-HBs level of less than 3 IU/l was considered negative. Anti-HAV, anti-HBc, HBsAg, and anti-HBe testing was done with a microparticle enzyme immunoassay (MEIA, Axsym, Abbott Laboratories). HBsAg-positive sera were retested with a confirmation assay (Abbott Laboratories). For anti-HBs testing, a quantitative MEIA was used, and for anti-HCV testing an enzyme-linked immunosorbent assay was used (ELISA, Axsym, Abbott Laboratories). Anti-HCVpositive sera were confirmed by recombinant immunoblot (Innogenetics).
Statistical analysis
Statistical analyses were performed using SPSS. To obtain prevalence figures of previous infection with HAV and HBV for the population in the neighborhood, weighted prevalences were calculated using inverse probability weighting by sex and ethnicity. In this procedure, weights are calculated for each of the 12 sex/ethnicity groups by dividing the proportion of a group in the neighborhood population by the proportion of that group in the study population. Differences in prevalence by sex and ethnicity were tested with Pearson's Chi-square test and by age group with Mantel-Haenszel Chisquare tests for linear association.
Results
Of the 1787 people invited, 288 responded and came to the community center. The overall response rate was 16%; women participated more often than men (19% and 13%, respectively). The response rate increased with age and was 10% in 18-29 year-olds, 17% in 30-44 year-olds, and 23% in 45-64 year-olds. Response also varied by ethnicity and was 9% in the Cape Verdean and Antillean groups, 17% in the Surinamese and Moroccan groups, 23% in the Dutch group, and 26% in the Turkish group. Fifty-five participants were Dutch (19%) and 233 non-Dutch (81%), of whom 90% were first generation migrants and 10% second generation migrants.
Hepatitis A and hepatitis B test results were available for 284 participants, and hepatitis C results for 271 participants.
The overall prevalence of antibodies to hepatitis A was 68%, and corresponded with a prevalence of 50% (95% confidence interval (CI) 44-55%) in the neighborhood when weighted by sex and ethnicity. The prevalence increased with age from 39% in the 18-29 years age group, to 85% in the 45-64 years age group ( p < 0.001). Dutch respondents had less evidence of previous HAV infection compared to non-Dutch respondents: 36% and 76%, respectively ( p < 0.001). The difference in prevalence was especially remarkable in the youngest age group, where none of the Dutch respondents had antibodies to HAV compared to 46% of the non-Dutch respondents. The anti-HAV prevalence varied in the different non-Dutch ethnic groups; while the overall prevalence was 50-55% in Surinamese and Antillean respondents, it was over 90% in the Turkish, Moroccan, and Cape Verdean respondents. Among non-Dutch respondents, the prevalence in FGM was higher than in SGM ( p < 0.001). The overall prevalence in SGM was similar to that in Dutch respondents, but the oldest age group was not represented among the SGM. The HAV prevalence in the 18-44 years age group was higher in SGM compared to Dutch respondents, but this difference was not statistically significant ( Table 1) .
The prevalence of anti-HBc, a marker for previous infection, was 20% (58/284) among respondents, and corresponded with a prevalence of 16% (95% CI 12-21%) in the neighborhood when weighted by sex and ethnicity. The prevalence increased with age from 8% in the 18-29 years age group, to 27% in the 45-64 years age group ( p = 0.003). Prevalence varied by ethnicity and was the lowest in Antillean participants (3%) and highest in Cape Verdean participants (57%). The difference in prevalence between Dutch participants and non-Dutch participants, 11% and 23%, respectively, was not statistically significant. The anti-HBc prevalence in FGM was higher than in SGM (25% and 4%, respectively; p = 0.02). The prevalence of anti-HBc is described in Table 2 .
The overall prevalence of HBsAg, indicating chronic infection and infectivity, was 0.7% (2/284; 95% CI 0.1-2.3%) -3.4% among anti-HBc-positives (2/58; 95% CI 0.6-10.9%). The two patients with markers for chronic hepatitis B were both FGM, a 41-year-old Turkish woman and a 53-year-old Antillean man. Except ethnicity, no other risk factors could be identified. The HBsAg prevalence in the total group of first generation immigrants was 1.0% (95% CI 0.3-3.5%).
In 17% of anti-HBc-positives, no other markers of HBV infection were found. If anti-HBc is present without HBsAg, anti-HBs, or anti-HBe this is called isolated anti-HBc. The prevalence of isolated anti-HBc varied by ethnicity and was 67% (4/6) among Dutch participants and 12% (6/52) among non-Dutch participants ( p = 0.006).
Three respondents (1.1%, 95% CI 0.4-3.2%) were positive for antibodies against HCV. They were a 57-year-old Surinamese man, a 20-year-old Moroccan man, and a 39-year-old Antillean man. None of them reported intravenous drug use, having had a tattoo, a piercing, contact with another person's blood, or a blood transfusion. The Surinamese man had had surgery in the Netherlands; the other two men had been subject to a medical procedure with a needle, the Moroccan man abroad and the Antillean man in the Netherlands. Viral hepatitis in a multi-ethnic neighborhood, the Netherlands e11 Of the 24 SGM, 17 (71%) had visited their parent's country of birth. Five of them (29%; two Turkish and three Surinamese) reported visiting a travel clinic and receiving vaccinations.
All respondents who were susceptible to hepatitis A and/ or hepatitis B were offered vaccination against hepatitis A and/or hepatitis B free of charge. Sixty-three of 227 participants (28%) took up the offer and visited the MPHS for vaccination.
Discussion
We found high levels of previous infection with hepatitis A and B in the multi-ethnic population of a neighborhood in Rotterdam. The prevalences of chronic HBV (0.7%) and hepatitis C (1.1%) were higher than previously reported in the national general population-based survey conducted in 1995/ 1996 (the Pienter study), which reported prevalences of 0.2% and 0.1%, respectively.
The response rate was lower than anticipated, despite the community-based approach. Due to the low response rate, the total number of participants was small, which makes comparisons between subgroups difficult. However, as we do not assume that selective response by the outcome of viral hepatitis testing has occurred, we consider the results of this study valid. Our study is of interest for the city of Rotterdam, but also for other cities with large immigrant populations.
In the Netherlands, vaccination against hepatitis A and B is not included in the National Immunization Program (NIP). However, since 2003, all children born to one or two parents born in intermediate or high endemic countries have been offered HBV immunization in the NIP. Furthermore, a vaccination program for high-risk groups (commercial sex workers, intravenous drug users, and men having sex with men) has been in place since 2002.
The prevalences of HAV and HBV markers in the study population were much higher than the general population estimates in the Netherlands, because non-Dutch respondents are over-represented in the targeted neighborhood in Rotterdam. The HAV prevalence of more than 90% among Turkish and Moroccan respondents (93% and 98%, respectively) is comparable to that among Turkish and Moroccan participants in the general population study (93% and 97%, respectively). 1 More than half of the participants of non-Dutch ethnicity in the youngest age group were susceptible to hepatitis A. The HBV prevalence found among Turkish and Moroccan respondents (38% and 12%, respectively) is comparable to that among Turkish and Moroccan participants in the general population study (39% and 19%, respectively). 2 The anti-HBc prevalence increased with age, a finding also observed in the general population study. 2 Participants aged 18-29 years have low rates of previous HBV infection; over 90% of them are probably vulnerable to HBV infection. A small part might be protected through vaccination, but we have no information about this, as participants without markers for previous or current HBV infection were not tested for the presence of protective antibodies. Ninety-three percent of the participants of non-Dutch ethnicity in the youngest age group had no markers of previous HBV infection. The anti-HBc prevalence was remarkably low in SGM, with only 1/24 SGM found positive. This could suggest vaccination in this group, which is however unlikely, as the pregnancy screening program only started in 1989 and the participants in this study were born before 1986. A possible explanation might be that the risk of horizontal transmission in the Netherlands is lower compared to that in the country of origin.
Five of the 17 SGM (29%; two Turkish and three Surinamese) who had visited their parent's country of birth, went to a travel clinic and were vaccinated. Although the type of vaccination was not recorded, it most likely included hepatitis A vaccination. These results indicate a low vaccination rate in SGM, especially Moroccan SGM, and many of them are probably at risk of becoming infected with HAV while visiting their home country. Active hepatitis A vaccination of Turkish and Moroccan children has also been argued in a study among children aged 5 to 16 years in Rotterdam. 5 We would recommend a more active approach in offering children in immigrant communities who did not receive HBV immunization as part of the NIP, a combined hepatitis A and B immunization.
As could be expected, the 0.7% prevalence of chronic HBV is also higher than the national estimate. The two HBsAgpositives were first generation immigrants, and the prevalence of HBsAg in the total group of first generation immi- grants was 1.0%, which seems low compared to the theoretically estimated HBsAg prevalence of 3.8% in first generation immigrants in the Netherlands. 3 Table 3 summarizes the anti-HBc and HBsAg prevalences found in two observational field studies in the Netherlands compared to the theoretical estimates.
It is not uncommon to find high rates of isolated anti-HBc. This serological profile can be the result of a previous infection with loss of measurable anti-HBs, of an ongoing lowgrade infection with undetectable HBsAg, or of a non-specific reaction, i.e., a false-positive test result. Especially in populations with a low prevalence of HBV markers, the probability of false-positive results increases. 6 Studies in blood donors in Brazil and Denmark reported false-positivity rates of 16% and 34%, respectively. 7, 8 The higher prevalence of isolated anti-HBc found in Dutch participants (4/6) compared to non-Dutch participants (6/52), and the absence of an increase in anti-HBc prevalence with age, suggests false-positive results. Therefore the prevalence of previous HBV infection of 11% in Dutch participants is most likely an overestimation. However, our study does not provide enough evidence to conclude which part of the cases of isolated anti-HBc were falsepositives, and therefore we have not excluded these cases when calculating the anti-HBc prevalence. To get more information on whether a person had a previous infection with waning anti-HBs, one would have to give the person an HBV vaccination and see if the anti-HBs response resembles a primary or a secondary response. Isolated anti-HBc has been shown to be associated with HCV, but none of the participants with isolated anti-HBc found in this study had antibodies to HCV. 9 The prevalence of HCV infection found is higher than the previous national estimate. Two of the three HCV-positive participants were remarkably young at 20 and 39 years of age. It is striking that the three HCV-infected respondents did not report risk factors for HCV infection. This is contrary to findings from a seroprevalence study in Amsterdam, where all HCV-positive individuals were aged 43 or older, with known HCV risk factors present in seven of nine. 10 In conclusion, the results of this study show that within low endemic countries, pockets with higher endemicity for viral hepatitis do exist. This confirms previous observations in ethnic subgroups from a national general population study and illustrates the high burden of viral hepatitis in areas with large immigrant populations. Viral hepatitis in a multi-ethnic neighborhood, the Netherlands e13
